The quorum quenching antibody RS2-1G9 protects macrophages from the cytotoxic effects of the Pseudomonas aeruginosa quorum sensing signalling molecule N-3-oxo-dodecanoyl-homoserine lactone

被引:60
作者
Kaufmann, Gunnar F. [1 ,2 ,3 ]
Park, Junguk [1 ,2 ,3 ]
Mee, Jenny M. [1 ,2 ,3 ]
Ulevitch, Richard J. [2 ]
Janda, Kim D. [1 ,2 ,3 ,4 ]
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA
关键词
quorum sensing; monoclonal antibody; Pseudomonas aeruginosa; acyl-homoserine lactone; immunopharmacotherapy;
D O I
10.1016/j.molimm.2008.01.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Gram-negative bacterium Pseudomonas aeruginosa, an opportunistic human pathogen, uses acyl-homoserine lactone-based quorum sensing systems to control its pathogenicity. One of its quorum sensing factors, N-3-oxo-dodecanoyl-homoserine lactone, has been shown not only to mediate bacterial quorum sensing but also to exert cytotoxic effects on mammalian cells. The monoclonal antibody RS2-1G9 generated against a 3-oxo-dodecanoyl-homoserme lactone analogue hapten was able to protect murine bone marrow-derived macrophages from the cytotoxic effects and also prevented the activation of the mitogen-activated protein kinase p38. These data demonstrate that an immunopharmacotherapeutic approach to combat P aeruginosa infections might be a viable therapeutic option as the monoclonal antibody RS2-1G9 can readily sequester bacterial N-3-oxo-dodecanoyl-homoserine lactone molecules, thus interfering with their biological effects in prokaryotic and eukaryotic systems. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2710 / 2714
页数:5
相关论文
共 41 条
[1]   Transcription of quorum-sensing system genes in clinical and environmental isolates of Pseudomonas aeruginosa [J].
Cabrol, SN ;
Olliver, A ;
Pier, GB ;
Andremont, A ;
Ruimy, R .
JOURNAL OF BACTERIOLOGY, 2003, 185 (24) :7222-7230
[2]   Passive antibody therapy for infectious diseases [J].
Casadevall, A ;
Dadachova, E ;
Pirofski, L .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (09) :695-703
[3]   The biology and future prospects of antivirulence therapies [J].
Cegelski, Lynette ;
Marshall, Garland R. ;
Eldridge, Gary R. ;
Hultgren, Scott J. .
NATURE REVIEWS MICROBIOLOGY, 2008, 6 (01) :17-27
[4]   Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection model [J].
Christensen, Louise D. ;
Moser, Claus ;
Jensen, Peter O. ;
Rasmussen, Thomas B. ;
Christophersen, Lars ;
Kielleberg, Staffan ;
Kumar, Naresh ;
Hoiby, Niels ;
Givskov, Michael ;
Bjarnsholt, Thomas .
MICROBIOLOGY-SGM, 2007, 153 :2312-2320
[5]   Targeting virulence: a new paradigm for antimicrobial therapy [J].
Clatworthy, Anne E. ;
Pierson, Emily ;
Hung, Deborah T. .
NATURE CHEMICAL BIOLOGY, 2007, 3 (09) :541-548
[6]   Crystal structures of a quorum-quenching antibody [J].
Debler, Erik W. ;
Kaufmann, Gunnar F. ;
Kirchdoerfer, Robert N. ;
Mee, Jenny M. ;
Janda, Kim D. ;
Wilson, Ian A. .
JOURNAL OF MOLECULAR BIOLOGY, 2007, 368 (05) :1392-1402
[7]   BACTERIAL BIOLUMINESCENCE - ISOLATION AND GENETIC-ANALYSIS OF FUNCTIONS FROM VIBRIO FISCHERI [J].
ENGEBRECHT, J ;
NEALSON, K ;
SILVERMAN, M .
CELL, 1983, 32 (03) :773-781
[8]   Autoinducer production and quorum-sensing dependent phenotypes of Pseudomonas aeruginosa vary according to isolation site during colonization of intubated patients [J].
Favre-Bonte, Sabine ;
Chamot, Eric ;
Koehler, Thilo ;
Romand, Jacques-A ;
van Delden, Christian .
BMC MICROBIOLOGY, 2007, 7 (1)
[9]   Quorum sensing: A novel target for anti-infective therapy [J].
Finch, RG ;
Pritchard, DI ;
Bycroft, BW ;
Williams, P ;
Stewart, GSAB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (05) :569-571
[10]   Listening in on bacteria: Acyl-homoserine lactone signalling [J].
Fuqua, C ;
Greenberg, EP .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (09) :685-695